| __timestamp | Galapagos NV | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 22732000 |
| Thursday, January 1, 2015 | 129714000 | 29245000 |
| Friday, January 1, 2016 | 139574000 | 33206000 |
| Sunday, January 1, 2017 | 218502000 | 31152000 |
| Monday, January 1, 2018 | 322876000 | 10136000 |
| Tuesday, January 1, 2019 | 427320000 | 45546000 |
| Wednesday, January 1, 2020 | 523667000 | 43367000 |
| Friday, January 1, 2021 | 1629000 | 81413000 |
| Saturday, January 1, 2022 | 12079000 | 139304000 |
| Sunday, January 1, 2023 | 35989000 | 192361000 |
| Monday, January 1, 2024 | 159417000 |
Unleashing insights
In the competitive landscape of biotechnology, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Halozyme Therapeutics, Inc. and Galapagos NV from 2014 to 2023. Over this period, Galapagos NV initially led with a higher cost of revenue, peaking in 2020. However, a dramatic shift occurred post-2020, with Halozyme Therapeutics, Inc. reducing its cost of revenue by approximately 70% by 2023, showcasing a strategic pivot towards efficiency. Meanwhile, Galapagos NV experienced a significant drop in 2021, with costs plummeting by over 99%, indicating potential restructuring or strategic realignment. This decade-long journey highlights the dynamic nature of financial strategies in the biotech sector, where adaptability and cost management are paramount for sustained growth and competitiveness.
Cost of Revenue: Key Insights for Novartis AG and Galapagos NV
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Galapagos NV
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs Halozyme Therapeutics, Inc.
Analyzing Cost of Revenue: Intra-Cellular Therapies, Inc. and Halozyme Therapeutics, Inc.
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.'s Expenses
Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs Wave Life Sciences Ltd.
Cost Insights: Breaking Down Pharming Group N.V. and Galapagos NV's Expenses
Cost Insights: Breaking Down Amneal Pharmaceuticals, Inc. and Galapagos NV's Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Galapagos NV
Cost of Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Galapagos NV
Comparing Cost of Revenue Efficiency: Agios Pharmaceuticals, Inc. vs Galapagos NV